Visakha Goonewardena, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Goonewardena’s office at (408) 993-1500 to ask if they take your plan before you enroll.
California Medical Board record
Licence A80630 · Current
Licensed to practise in California · since 2002 · expires 2028-04-30 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 13 Part D prescriptions in 2021. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2021 | 13 | None | 0% (0) | None | $1,830 |
| 2020 | 105 | 12 | 0% (0) | 16% | $10,014 |
| 2019 | 212 | 22 | None | 23% | $26,849 |
| 2018 | 246 | 23 | 0% (0) | 25% | $36,450 |
| 2017 | 210 | 25 | None | 19% | $20,388 |
| 2016 | 243 | 28 | 0% (0) | 14% | $14,728 |
| 2015 | 230 | 27 | 0% (0) | 16% | $14,173 |
| 2014 | 308 | 29 | 0% (0) | 24% | $26,433 |
| 2013 | 347 | 26 | None | 29% | $31,562 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 3 drugs
| Levothyroxine | 12 | $383 | $32 |
| Atorvastatin | 12 | $233 | $19 |
| Losartan | 12 | $107 | $9 |
2019: 2 drugs
| Levothyroxine | 18 | $474 | $26 |
| Atorvastatin | 15 | $304 | $20 |
2018: 5 drugs
| Advair Diskus | 16 | $15,570 | $973 |
| Metoprolol | 11 | $801 | $73 |
| Levothyroxine | 16 | $544 | $34 |
| Atorvastatin | 17 | $445 | $26 |
| Amlodipine Besylate | 11 | $137 | $12 |
2017: 4 drugs
| Metoprolol | 13 | $448 | $34 |
| Atorvastatin | 13 | $236 | $18 |
| Lisinopril | 13 | $145 | $11 |
| Amlodipine Besylate | 13 | $89 | $7 |
2016: 4 drugs
| Atorvastatin | 17 | $328 | $19 |
| Metoprolol | 19 | $165 | $9 |
| Amlodipine Besylate | 16 | $122 | $8 |
| Atenolol | 11 | $57 | $5 |
2015: 6 drugs
| Atorvastatin | 12 | $298 | $25 |
| Atenolol | 18 | $149 | $8 |
| Lisinopril | 14 | $112 | $8 |
| Amlodipine Besylate | 19 | $99 | $5 |
| Olanzapine | 12 | $86 | $7 |
| Metoprolol | 12 | $74 | $6 |
2014: 6 drugs
| Atorvastatin | 16 | $865 | $54 |
| Amlodipine Besylate | 17 | $298 | $18 |
| Lisinopril | 20 | $199 | $10 |
| Atenolol | 22 | $119 | $5 |
| Glipizide | 11 | $116 | $11 |
| Hydrochlorothiazide | 11 | $81 | $7 |
2013: 10 drugs
| Clonidine | 11 | $4,438 | $403 |
| Advair Diskus | 13 | $3,328 | $256 |
| Atorvastatin | 20 | $1,385 | $69 |
| Amlodipine Besylate | 24 | $295 | $12 |
| Levothyroxine | 17 | $196 | $12 |
| Atenolol | 26 | $193 | $7 |
| Lisinopril | 13 | $165 | $13 |
| Simvastatin | 13 | $164 | $13 |
| Omeprazole | 11 | $155 | $14 |
| Glipizide | 12 | $137 | $11 |
Money from drug and device companies
$22 in 2020
A payment is not proof that care is biased.
| Boehringer Ingelheim Pharmaceuticals | Ofev | $22 | 1 payment
|
See the published payment
| Boehringer Ingelheim Pharmaceuticals | Meals · 2020-03-10 | Ofev | $22 |
Professional record
- NPI
- 1326145673
- Licence
- CA A80630California A80630: Current · expires 2028-04-30
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 105 N Bascom Ave, Suite 202, San Jose, CA, 95128
- NPI first listed
- 2006-09-20
- NPI last updated
- 2009-10-09
This is when the NPI record was last certified, not a medical board exam.